News
MBXBF
0.166
NaN%
--
Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand
TipRanks · 3d ago
Microbix Biosystems reports Q2 EPS (C$0.01) vs. C$0.00 last year
TipRanks · 6d ago
Microbix Biosystems says ‘agressively pursuing’ new client programs
TipRanks · 6d ago
Microbix Biosystems GAAP EPS of -$0.01, revenue of $3.38M
Seeking Alpha · 6d ago
Canada's Microbix Biosystems Q2 revenue falls 37% on weaker China sales
Reuters · 6d ago
MICROBIX BIOSYSTEMS Q2 REVENUE CAD 3.37 MILLION
Reuters · 6d ago
MICROBIX BIOSYSTEMS Q2 GROSS MARGIN 48%
Reuters · 6d ago
MICROBIX BIOSYSTEMS Q2 EPS CAD -0.01
Reuters · 6d ago
Microbix Q2 FY26 net loss widens to C$ 1.43 million; revenue drops 37% to C$ 3.38 million
PUBT · 6d ago
Microbix sets Q2 fiscal 2026 results release and investor webinar
PUBT · 05/07 11:16
Microbix Biosystems says client presenting product results at 2026 PASCV
TipRanks · 04/27 11:31
Stocks in play: Microbix Biosystems Inc.
Barchart · 04/27 09:06
Microbix Biosystems releases episodes of ‘Diagnostics: Beyond the Lab’ podcast
TipRanks · 04/20 11:56
Stocks in play: Microbix Biosystems Inc.
Barchart · 04/20 09:00
Microbix to Court Global Healthcare Investors at 2026 Bloom Burton Conference
TipRanks · 04/16 12:10
Microbix to present at Bloom Burton Healthcare Investor Conference
PUBT · 04/16 09:02
Microbix Showcases Novel RNA Assay Controls at ESCMID Global 2026
TipRanks · 04/15 11:58
Microbix Biosystems presenting results of QAP at ESCMID Global 2026
TipRanks · 04/15 11:21
Stocks in play: Microbix Biosystems Inc.
Barchart · 04/15 10:09
Microbix presents study results on phage-encapsulated RNA control for PCR assays
PUBT · 04/15 09:02
More
Webull provides a variety of real-time MBXBF stock news. You can receive the latest news about Microbix Biosys through multiple platforms. This information may help you make smarter investment decisions.
About MBXBF
Microbix Biosystems Inc. is a Canada-based company. The Company develops and commercializes proprietary biological and technology solutions for human health and wellbeing. It manufactures a range of critical biological materials and medical devices for the global diagnostics industry, notably test ingredients (Antigen business) used in immunoassays, quality assessment and proficiency testing controls (QAPsTM business), and sample collection devices (DxTMTM business). The Company operates in two ways: (i) the development, manufacturing, and sale of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples, and (ii) the development and commercialization of novel and proprietary products or technologies such as Kinlytic. It's Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots.